Percutaneous coronary intervention in the context of systemic inflammation: More injury and worse outcome

Medical Science Monitor

Volumn 9, Issue 8, 2003, Pages

  Saadeddin, Salam M ^a   Habbab, Moh'd A ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

C reactive protein; Minor myocardial injury; Percutaneous coronary intervention; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN; TROPONIN I;

ANGIOGRAPHY; ARTIFICIAL EMBOLISM; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RISK; DISEASE MARKER; DISEASE SEVERITY; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; LONG TERM CARE; MICROEMBOLISM; REVIEW; RISK FACTOR; STABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HEART INJURIES; HUMANS; INFLAMMATION; TROPONIN I;

EID: 0141595184     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Ross R: Atherosclerosis: an inflammatory disease. New Engl J Med, 1999; 340: 115-126
2. Libby P, Ridker PM: Novel inflammatory markers of coronary risk. Theory versus Practice. Circulation, 1999; 100: 1148-1150
3. Saadeddin SM, Habbab MA, Fern GA: Markers of inflammation and coronary artery disease. Med Sci Monit, 2002; 8: 5-12
4. Kinlay S, Selwyn AP, Libby P, Ganz P: Inflammation, the endothelium and acute coronary syndromes. J Cardiovasc Pharmacol, 1998; 23(Suppl 3): 62-66
5. Katus HA, Remppis A, Neumann FJ et al: The diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation, 1991; 83: 902-912
6. Antman EM, Tanasijevic MJ, Thompson B et al: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Eng J Med, 1996; 335: 1342-1349
7. Saadeddin SM, Habbab MA, Ferns GA: Cardiac markers for assessing the acute coronary syndromes. A focus on cardiac troponins. Saudi Med J, 2000; 21: 228-237
8. Sobki SH, Saadeddin SM, Habbab MA: Cardiac markers used in the detection of myocardial injury. Saudi Med J, 2000; 91: 843-846
9. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA: Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting. Med Sci Monit, 2000; 6: 708-712
10. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA: Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins. Cathet Cardiovasc Intervent, 2001; 53: 188-192
11. Kugelmass AD, Cohen DJ, Mascucci M et al: Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol, 1994; 74: 748-754
12. Abdelmeguid AE, Topol EJ, Whitlow PL et al: Significance of mild transient release of creatine kinase MB fraction after percutaneous interventions. Circulation, 1996; 94: 1528-1536
13. Karim MA, Shinn M, Oskarsson H et al: Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol, 1995; 76: 521-523
14. Hunt AC, Chow SL, Shiu MF et al: Release of creatine kinase-MB and cardiac specific troponin I following percutaneous transluminal coronary angioplasty. Eur Heart J, 1991; 12: 690-694
15. Genser N, Mair J, Friedrich G et al: Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentration. Am J Cardiol, 1996; 78: 127-128
16. Waksman R, Scott NA, Douglas JS et al: Distal embolization is common after directional atherectomy in coronary arteries and vein grafts. Circulation, 1993; 88(suppl 1): 299
17. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA: Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol, 2002; 89: 981-983
18. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA: Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome. Ann Clin Biochem, 2002; 39: 392-397
19. Bertinchant J, Polge A, Ledermann B et al: Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol, 1999; 84: 51-57
20. Garbarz E, Lung B, Lefevre G et al: Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol, 1999; 84: 515-518
21. Sluiter W, Pietersma A, Lamers JMJ, Koster JF: Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanism underlying their expression. J Cardiovasc Pharmacol, 1993; 22: 37-44
22. Kloner RA, Giacomelli F, Alker KJ et al: Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia-reperfusion. Circulation, 1991; 84: 1758-1772
23. Azar RR, McKay RG, Kiernan FJ DB, Wu AHB, Waters DD: Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol. 1997; 80: 147-1478
24. Munro JM, Cotran RS: The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest, 1988; 58: 249-261
25. Ricevnti G, Mazzone A, Pasotti D et al: Role of granulocytes in endothelial injury in coronary heart disease in humans. Atherosclerosis, 1991; 91: 1-14
26. Azar RR, Water DD: The inflammatory etiology of unstable angina. Am Heart J, 1996; 132: 1101-11015
27. Heinrich J, Schulte H, Schonfeld R et al: Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas, 1995; 73: 374-378
28. ECAT Angina Pectoris Study group: ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J, 1993; 14: 8-17
29. Rifai N, Joubran R, Yu H et al: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem, 1999; 45: 1967-1973
30. Du Clos TW: Function of C-reactive protein. Ann Med, 2000; 32: 274-278
31. Lagrand WK, Visser CA, Hermens WT et al: C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation, 199; 100: 96-102
32. Reynolds GD, Vance RP: C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med, 1987; 111: 265-269
33. Torzewski M, Rist C, Mortensen RF et al: C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol, 2000; 20: 2094-2099
34. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect or C-reactive protein on human endothelial cells. Circulation, 2000; 102: 2165-2168
35. Pasceri V, Chang J, Willerson JT et al: Modulation of c-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001; 103: 2531-2534
36. Nakagomi A, Freedman SB, Geczy CL: Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment Circulation, 2000; 101: 1785-1791
37. Ridker PM, Cushman M, Stampfer MJ et al: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336: 973-979
38. Ridker PM, Rifai N, Pfeffer MA et al: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation, 1999; 100: 230-235
39. The EPIC Investigators: Use ofa monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med, 1994; 330: 956-961
40. The EPILOC Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous revascularization. N Engl J Med, 1997; 336: 1689-1696
41. Mishkel GJ, Aguirre FV, Rocha-Singh KJ, Lucore CL: Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J AM Coll Cardiol, 1999; 34: 1884-1890
42. Waters DD: Early pharmacologic intervention and plaque stability in acute coronary syndromes. Am J Cardiol, 2001; 88: 30-36